The increasing demand for safer, more sustainable alternatives to chemical-based medicines has prompted significant interest in plant-derived bioactive compounds, which are known to possess a wide range of therapeutic properties. Among these, Phyla nodiflora (L.) is the one, a medicinal plant commonly called Jalapippali used in Ayurveda, Siddha, and traditional Southeast Asian medicine. It belongs to the Verbenaceae family. It grows in tropical and subtropical regions worldwide and is valued for its abundant therapeutic properties, mainly to treat skin diseases, fever, cough, wounds, and inflammation, even diabetes. Jalapippali is referenced in several Nighantus of Ayurveda. Although there are few mentions in Ayurveda Brihatrayee, most Nighantus have emphasized its medicinal value over time. Even the oldest Nighantu, Dhanvantari Nighantu, mentions it. Many experts suggest that the plant is rich in various important medicinal compounds such as nodiflorin, nodifloretin, lippiflorins, etc. While modern research has explored its properties, clinical studies remain scarce. Given its diverse medicinal potential, Phyla nodiflora warrants greater attention from the scientific community. Future research focusing on its pharmacological properties, bioavailability, and therapeutic applications could pave the way for its integration into modern medicine. Enhancing public awareness and promoting its utilization through validated studies may contribute to unlocking its full medicinal potential.